Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Return on Invested Capital (ROIC) | 28.8% | 96.7% | 84.8% | 9.6% | (28.2%) | 8.4% | 30.8% | 53.3% | 52.4% | 29.9% | 51.4% | 40.3% | 88.3% | 51.0% | 60.2% | (11.3%) | 41.5% | 39.0% | 64.7% | 64.7% |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Microsoft Corp's last 12-month Return on Invested Capital (ROIC) is 70.4%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Return on Invested Capital (ROIC) for United Therapeutics Corporation have been 62.8% over the past three years, and 55.3% over the past five years.
As of today, United Therapeutics Corporation's Return on Invested Capital (ROIC) is 70.4%, which is higher than industry median of (123.1%). It indicates that United Therapeutics Corporation's Return on Invested Capital (ROIC) is Good.